Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels

This publication has 35 references indexed in Scilit:

• Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
  Journal of Molecular Medicine, 1988
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
  Nature, 1987
• Coronary risk prediction in adults (The Framingham Heart Study)
  The American Journal of Cardiology, 1987
• Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
• High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease
  The American Journal of Cardiology, 1983
• Protein composition of Lp(a) lipoprotein from human plasma
  FEBS Letters, 1983
• Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
  New England Journal of Medicine, 1982
• Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle‐aged males
  Clinical Genetics, 1979
• Lp(a) lipoprotein/pre‐ß₁‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease
  Clinical Genetics, 1975
• A study of methods of identification and estimation of LP(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis
  Atherosclerosis, 1974